Fig. 6
From: A novel prognostic cancer-related lncRNA signature in papillary renal cell carcinoma
Expression of RP11-63A11.1 in different clinicopathological features. A Bodymap of RP11-63A11.1 in human normal tissues and tumor tissues. B RP11-63A11.1 expression in different tumor stage (I–II vs. III–IV). C RP11-63A11.1 expression in different gender (female vs. male). D RP11-63A11.1 expression in different age group. E RP11-63A11.1 expression in different T classification (T1–T2 vs. T3–T4). F RP11-63A11.1 expression in different M classification (M0 vs. M1). G RP11-63A11.1 expression in different N classification (N0 vs. N1–N2)